1. Bing-Neel syndrome presenting as isolated CNS lymphoplasmacytic lymphoma: A case report and review of the literature. (January 2020) Authors: Grainger, Brian T.; Issa, Samar Journal: Journal of clinical neuroscience Issue: Volume 71(2020) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds. (2nd April 2014) Authors: Bouaziz, Zouhair; Issa, Samar; Gentili, Jacques; Gratz, Andreas; Bollacke, Andre; Kassack, Matthias; Jose, Joachim; Herfindal, Lars; Gausdal, Gro; Døskeland, Stein Ove; Mullié, Catherine; Sonnet, Pascal; Desgrouas, Camille; Taudon, Nicolas; Valdameri, Glaucio; Di Pietro, Attilio; Baitiche, Milad;... Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 30:Number 2(2015:Apr.) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Carbazole scaffolds in cancer therapy: a review from 2012 to 2018. (1st January 2019) Authors: Issa, Samar; Prandina, Anthony; Bedel, Nicolas; Rongved, Pål; Yous, Saïd; Le Borgne, Marc; Bouaziz, Zouhair Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 34:Number 1(2019) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CLRM-15 TRIAL IN PROGRESS: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT INHIBITOR OF BRUTON'S TYROSINE KINASE (BTKI) FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA (R/R PCNSL/SCNSL) AND PRIMARY VITREORETINAL LYMPHOMA (PVRL). (5th August 2022) Authors: Soussain, Carole; Grommes, Christian; Issa, Samar; Ward, Renee; Peterson, Caryn; Cravets, Matt; Mathias, Anita; Sosa, Judith; Kirby, Brian; Ding, Zhaoqing; Yusuf, Isharat; Rose, Mark; Steinberg, Marcos; Tun, Han W Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Extent of radiological response does not reflect survival in primary central nervous system lymphoma. Issue 1 (15th February 2021) Authors: van der Meulen, Matthijs; Postma, Alida A; Smits, Marion; Bakunina, Katerina; Minnema, Monique C; Seute, Tatjana; Cull, Gavin; Enting, Roelien H; van der Poel, Marjolein; Stevens, Wendy B C; Brandsma, Dieta; Beeker, Aart; Doorduijn, Jeanette K; Issa, Samar; van den Bent, Martin J; Bromberg, Jacol... Journal: Neuro-oncology advances Issue: Volume 3:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience. (16th July 2020) Authors: Lewis, Katharine L.; Chin, Collin K.; Manos, Kate; Casey, John; Hamad, Nada; Crawford, Julie; Ho, Shir‐Jing; Issa, Samar; Grigg, Andrew; Wood, Peter; Gandhi, Maher K.; Do, Bryan; Nastoupil, Loretta; Hawkes, Eliza A.; Cheah, Chan Y. Journal: British journal of haematology Issue: Volume 192:Number 6(2021) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NCOG-05. IMPACT OF ADDITIONAL RITUXIMAB TO STANDARD THERAPY ON COGNITIVE PERFORMANCES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS. (11th November 2019) Authors: van der Meulen, Matthijs; Dirven, Linda; Habets, Esther; Bakunina, Katerina; Taphoorn, Martin; van den Bent, Martin; Issa, Samar; Doorduijn, Jeanette K; Bromberg, Jacoline E C Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial. Issue 8 (9th February 2021) Authors: van der Meulen, Matthijs; Dirven, Linda; Habets, Esther J J; Bakunina, Katerina; Smits, Marion; Achterberg, Hakim C; Seute, Tatjana; Cull, Gavin; Schouten, Harry; Zijlstra, Josée M; Brandsma, Dieta; Enting, Roelien H; Beijert, Max; Taphoorn, Martin J B; van den Bent, Martin J; Issa, Samar; Doordu... Journal: Neuro-oncology Issue: Volume 23:Issue 8(2021) Page Start: 1315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Obese non-Hodgkin lymphoma patients tolerate full uncapped doses of chemotherapy with no increase in toxicity, and a similar survival to that seen in nonobese patients. Issue 11 (1st November 2016) Authors: Chan, Henry; Jackson, Sharon; McLay, Jessica; Knox, Angela; Lee, Jae; Wang, Sarah; Issa, Samar Journal: Leukemia & lymphoma Issue: Volume 57:Issue 11(2016:Nov.) Page Start: 2584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Primary idiopathic CNS non-amyloidogenic light chain deposition disease complicated by treatment-resistant focal seizure disorder. (January 2019) Authors: Grainger, Brian T.; Issa, Samar; Anderson, Neil E. Journal: Journal of clinical neuroscience Issue: Volume 59(2019) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗